Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.000
-0.010 (-0.99%)
Jul 8, 2026, 4:00 PM EDT - Market closed
Cardiol Therapeutics Employees
Cardiol Therapeutics had 18 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
18
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,446,731
Market Cap
117.04M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 18 | 0 | - |
| Dec 31, 2024 | 18 | - | - |
| Dec 31, 2018 | 6 | - | - |
| Sep 30, 2018 | 8 | - | - |
| Jun 30, 2018 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,120 |
| Aurora Cannabis | 1,028 |
| Lifecore Biomedical | 382 |
| InterCure | 285 |
| Anika Therapeutics | 235 |
| ADC Therapeutics | 193 |
| Cumberland Pharmaceuticals | 93 |
| Journey Medical | 58 |
CRDL News
- 13 days ago - Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders - PRNewsWire
- 15 days ago - Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on June 24th at 4:30 p.m. EDT - PRNewsWire
- 7 weeks ago - Cardiol Therapeutics to Participate in Fireside Chat at H.C. Wainwright 4th Annual BioConnect Investor Conference at the NASDAQ - PRNewsWire
- 2 months ago - Cardiol Therapeutics Registration statement: Q1 2026 - Filings
- 2 months ago - Cardiol Therapeutics Registration statement: Q1 2026 - Filings
- 2 months ago - Cardiol Therapeutics Slides: Corporate presentation - Filings
- 2 months ago - Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association - PRNewsWire
- 2 months ago - Cardiol Therapeutics (CRDL) Expands MAVERIC Trial with New Clinical Sites - GuruFocus